Bausch Health Companies Inc. (BHC) P/E ratio
The P/E ratio of Bausch Health Companies Inc. (BHC) was 16.5× at the end of fiscal 2025 (December 31, 2025). Figures as of 18 Nov 2026, 07:14 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/E ratio, fiscal 2025
- 16.5×
- Highest on record
- 95.3×fiscal 2011
- Lowest on record
- 3.0×fiscal 2017
- Fiscal years on record
- 62008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Bausch Health Companies Inc. P/E ratio, in more detail
Across the 6 fiscal year-ends on record (2008–2025), the highest was 95.3× in fiscal 2011 and the lowest 3.0× in fiscal 2017.
P/E ratio at each fiscal year-end
Bausch Health Companies Inc. P/E ratio, year by year
| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 16.5× | — | $6.95 | $0.42 | |
| 2024 | — | — | $8.06 | -$0.13 | |
| 2023 | — | — | $8.02 | -$1.62 | |
| 2022 | — | — | $6.28 | -$0.62 | |
| 2021 | — | — | $27.61 | -$2.64 | |
| 2020 | — | — | $20.80 | -$1.58 | |
| 2019 | — | — | $29.92 | -$5.08 | |
| 2018 | — | — | $18.47 | -$11.81 | |
| 2017 | 3.0× | — | $20.78 | $6.83 | |
| 2016 | — | — | $14.52 | -$6.94 | |
| 2015 | — | — | $101.65 | -$0.85 | |
| 2014 | 55.5× | — | $143.11 | $2.58 | |
| 2013 | — | — | $117.40 | -$2.70 | |
| 2012 | — | — | $59.77 | -$0.38 | |
| 2011 | 95.3× | — | $46.69 | $0.49 | |
| 2010 | — | — | $28.29 | -$1.06 | |
| 2009 | 12.6× | 66.4% up | $13.96 | $1.11 | |
| 2008 | 7.6× | — | $9.45 | $1.25 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
How to read it
It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.
Bausch Health Companies Inc., figure by figure
- Bausch Health Companies Inc. market cap
- Bausch Health Companies Inc. revenue
- Bausch Health Companies Inc. earnings
- Bausch Health Companies Inc. earnings per share (EPS)
- Bausch Health Companies Inc. P/S ratio
- Bausch Health Companies Inc. P/B ratio
- Bausch Health Companies Inc. free cash flow
- Bausch Health Companies Inc. operating margin
- Bausch Health Companies Inc. dividend
- Bausch Health Companies Inc. shares outstanding
- Bausch Health Companies Inc. total debt
- Bausch Health Companies Inc. cash on hand
- Bausch Health Companies Inc. total assets
- Bausch Health Companies Inc. return on equity (ROE)
- Bausch Health Companies Inc. return on invested capital (ROIC)
Bausch Health Companies Inc. (BHC) overview: price, valuation and scorecard
Bausch Health Companies Inc. P/E ratio: questions and answers
What is Bausch Health Companies Inc.'s P/E ratio?
The P/E ratio of Bausch Health Companies Inc. (BHC) was 16.5× at the end of fiscal 2025 (December 31, 2025).
What are the highest and lowest P/E ratio figures on record for Bausch Health Companies Inc.?
Across the 6 fiscal year-ends on record (2008–2025), the highest was 95.3× in fiscal 2011 and the lowest 3.0× in fiscal 2017.
How is Bausch Health Companies Inc.'s P/E ratio calculated?
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/E ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Bausch Health Companies Inc. (BHC) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/BHC/pe-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.